Your trusted source for investing success

Tag: THC

Biotech Stocks in 2018

Find out how the market will look this year
 
Isodiol International Inc. Signs Licensing Agreement with Level Brands Inc. and Its Chairman Emeritus And Chief Brand Strategist Kathy Ireland

Isodiol International Inc. Signs Licensing Agreement with Level Brands Inc. and Its Chairman Emeritus And Chief Brand Strategist Kathy Ireland

Isodiol International Inc., (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F)(the “Company” or “Isodiol”), a global bioactive phytoceutical innovator specializing in the development of pharmaceutical and wellness products, announced today that it has entered into a licensing agreement with Level Brands Inc. (NYSE American:LEVB), an innovative marketing and licensing company that provides bold, unconventional and socially

Phivida Signs Distribution Agreement in Japan

Phivida Signs Distribution Agreement in Japan

Phivida Holdings Inc. (CSE:VIDA) is pleased to report that it has entered into a product distribution agreement with Asayake Inc. (“Asayake”) to sell its cannabidiol (“CBD”) products across Japan.

This new strategic distribution agreement is part of a greater global expansion strategy and equips Phivida with an early mover status and

Phivida Launches High Performance Nano-CBD™

Phivida Launches High Performance Nano-CBD™

Phivida Holdings Inc. (CSE:VIDA) is pleased to announce the launch of its flagship line of high performance Nano-CBD™ (nanoencapsulated-cannabidiol) infused beverages into the US athletic and sports medicine market.

Phivida Nano-CBD™ Sport line of beverages are designed to maximize physical, mental performance for athletes, fitness professionals and everyday health conscious consumers.

Phivida Enters into Supply Agreement with Artelo Biosciences

Phivida Enters into Supply Agreement with Artelo Biosciences

Phivida Holdings Inc. (“Phivida” – “C.VIDA” – “US.PHVAF”) is pleased to report that Phivida Organics Inc., a wholly owned US operating subsidiary of Phivida, has entered into a product formulation and wholesale supply agreement with Artelo Biosciences, Inc. (“Artelo”, OTCBB: ARTL).

Valens GroWorks Announces $5,000,000 Funding

Valens GroWorks Announces $5,000,000 Funding

Valens GroWorks Corp. (CSE:VGW) (the “Company” or “Valens”), a multi-licenced, vertically integrated provider of cannabis products, is pleased to announce it has arranged for a $5,000,000 private placement consisting of 3,571,429 shares at a price of $1.40 per share (the “Offering”).

Proceeds of the Offering will be used for additional growing

Valens GroWorks Receives Processing License

Valens GroWorks Receives Processing License

Valens GroWorks Corp. (CSE: VGW) (the “Company” or “Valens”), a multi-licensed, vertically integrated provider of cannabis products, is pleased to announce it has been granted Health Canada approval for the manufacture and packaging of cannabis oil products for sale to Licensed Producers, Licensed Dealers and approved Clinical Trials.

Phivida Launches CBD Products into USA Clinical Markets

Phivida Launches CBD Products into USA Clinical Markets

Phivida Holdings Inc. (CSE:VIDA) is pleased to report the official launch of its clinical grade cannabidiol products into the USA clinical market under the brand name Vida+. The launch of Vida+ CBD is coincided with a national clinical education campaign focused on providing the US alternative healthcare community with validated data on

INDIVA Limited Signs Exclusive Supply Agreement with Swiss Cannabis Producer

INDIVA Limited Signs Exclusive Supply Agreement with Swiss Cannabis Producer

INDIVA Limited (“Indiva” or the “Company) (TSX VENTURE:NDVA) is pleased to announce that it has entered into a strategic cooperation agreement (the “Agreement”) with Medropharm GmbH and Greenfields Health Care S.A. (together, the “Licensors”) with respect to the exclusive supply by the Licensors of multiple premium cannabis strains for cultivation

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

Isodiol International Inc. Announces Binding Agreement to Acquire Biosynthesis Pharma Group

Isodiol International Inc. (CSE:ISOL) (OTC:ISOLF) (FSE:LB6A.F) (the “Company” or “Isodiol”), a global Bioactive Phytoceutical innovator specializing in the development of pharmaceutical and wellness products, is pleased to announce that the Company has entered into a binding agreement to acquire the Biosynthesis Pharma Group (BSPG), an industry leading producer of industrial hemp, it’s derivatives

10+ Gold Stocks to Watch

Stocks.
Expert Insights.
Industry Stats.


Give me my free report!
Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×

Privacy & Legal Policy

Privacy Policy

×
Investing News Network

Send this to a friend

Hi,
I thought you might find this interesting:
Phivida Launches Nano-CBD™ Iced Tea Product Line

URL: https://investingnews.com/daily/resource-investing/agriculture-investing/cannabis-investing/phivida-launches-nano-cbd-iced-tea-product-line/